Workflow
elixorexant
icon
Search documents
Alkermes(ALKS) - 2025 Q2 - Earnings Call Transcript
2025-07-29 13:02
Alkermes (ALKS) Q2 2025 Earnings Call July 29, 2025 08:00 AM ET Company ParticipantsSandy Coombs - SVP - Corporate Affairs & IRRichard Pops - Chairman & CEOBlair Jackson - Executive VP & COOTodd Nichols - SVP & Chief Commercial OfficerCraig Hopkinson - EVP, R&D and Chief Medical OfficerMarcus Yountz - VP - Clinical DevelopmentPaul Matteis - Managing Director, Head of Therapeutics ResearchAnastasia Parafestas - Equity Research AssociateAndrea Newkirk - Biotechnolgy Equity ResearchUmer Raffat - Senior Managin ...
Alkermes(ALKS) - 2025 Q2 - Earnings Call Transcript
2025-07-29 13:00
Alkermes (ALKS) Q2 2025 Earnings Call July 29, 2025 08:00 AM ET Speaker0Greetings, and welcome to the Alkermes Second Quarter twenty twenty five Financial Results Conference Call. My name is Rob, and I'll be your operator for today's call. All participant lines will be placed on mute to prevent background noise. Please note that this conference is being recorded. I'll now turn the call over to Sandra Coombs, Senior Vice President of Investor Relations and Corporate Affairs.Sandy, you may now begin.Speaker1G ...